Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: The health director for Ridgefield, Connecticut, says there is no way that he and his staff of two can identify and isolate all the people who have interacted with an infected patient, not at the rate cases are multiplying across the town. “Tracing exposures of exposures of exposures. It’s just impossible,” Briggs said. “The cases are to the point where we can’t possibly trace everybody back now.”  Known as contact tracing, this vital but labor-intensive process is becoming increasingly difficult for stretched health departments in towns and cities across the United States, which has more than 160,000 cases, more than any country in the world. A massive testing campaign, coupled with intensive contact tracing, is credited with helping South Korea slow the spread of coronavirus, whereas the United States has been criticized for a slow response. Epidemiologists say such investigations can mean the difference between nipping an outbreak early and effectively losing control, as has happened in hot spots where contact tracing has given way to lockdowns as the primary tool to prevent spread. Some states outside of the major population centers have taken that advice to heart, as the virus continues its march across the United States. Health officials in those areas acknowledge, however, that it is a race against the clock and that they, too, will be unable to carry out such widespread tracing if the case numbers climb beyond a certain point. Wyoming, for one, has five staff in its state’s infectious diseases unit working to identify all contacts with a person who has tested positive, and then asking or ordering them to self-quarantine, and monitoring their health. “Our numbers are small enough,” said Kim Deti, a spokeswoman for Wyoming’s health department, which has reported 109 cases so far and no deaths. “We’ll maintain it as long as we can.”  West Virginia is tapping its national guard to assist in a similar effort at expansive contact tracing, and coupling that with a stay-at-home order and other distancing steps. On Sunday, the state reported 145 cases and its first coronavirus death. “It’s incredibly important that at the same time as you are doing that rapid contact investigation and tracing and outbreak management, that we do the preventive measures in partnership with that everywhere,” state health officer Cathy Slemp said at a news conference last week. Alabama, which has confirmed nearly 1,000 cases, is attempting to investigate contacts for all of them, a spokeswoman for its health department said, noting that contact tracing has been an “effective tool in reducing the spread” for tuberculosis and other communicable diseases in the state. New York City, which accounts for a quarter of all cases nationwide, is an example of how the lack of testing in January and February handicapped so-called “disease detectives” from identifying initial infections and containing the spread. The city is now limiting its detectives to contact tracing for outbreaks involving health care workers and clusters in assisted living facilities and nursing homes, its health commissioner, Oxiris Barbot, said during a news conference earlier this month. Louisiana, an emerging hot spot with 5,237 cases and 239 deaths, has similarly narrowed its contact tracing in the New Orleans area, the epicenter of the state’s outbreak, to focus on vulnerable populations and high-risk groups. Theresa Sokol, an assistant state epidemiologist in Louisiana, said that by the time the initial patients in the New Orleans area were identified the virus had already taken hold in the community. As cases mounted, she said, social distancing became a more effective tool than contact tracing. But outside New Orleans there is reason to believe that digging deeply into all cases can yield results, especially when combined with the governor’s statewide stay-at-home order, Sokol said: “I believe that there is still time.”  Like other municipalities in the New York area, Ridgefield closed its schools and non-essential businesses. But the virus has continued to spread broadly beyond the cluster at the Benchmark Senior Living at Ridgefield Crossings facility, which has been linked to six of the town’s seven deaths. The town hired an additional employee to process the deluge of coronavirus-related data, but keeping up is a challenge. “It’s overwhelming for a small health department,” First Selectman Rudy Marconi said. Looking ahead, experts see aggressive testing and contact tracing as key to handling subsequent waves of the virus. Kenneth Castro, a professor of global health, epidemiology, and infectious diseases at Emory University, said local, state and federal governments should start recruiting an “army” of people to handle contact investigations. “Identify and contain is better than having society shutdown. It’s a balancing act,” said Castro, who oversaw the Centers for Disease Control and Prevention’s tuberculosis effort for two decades through 2013. “We won’t be able to maintain physical distancing forever.”  (This story has been refiled to correct spelling of “stretched” in paragraph four.)

Output: 'It's just impossible': tracing contacts takes backseat as virus spreads.


Input: Consider Input: The Seattle Times reports the child was elementary-school age and died in a Pierce County hospital Dec. 15, according to a statement from Public Health — Seattle & King County. Three King County adults also have died since the start of this flu season, which began unusually early and is especially affecting children, health officials said. Health Officer Dr. Jeff Duchin said the predominant strain circulating right now is the influenza B virus. Officials are urging people to get vaccinated. There are also anti-viral treatments available after flu-like symptoms appear, which can prevent people from getting sicker or developing complications, Duchin said. Duchin declined to say whether the child who died had been vaccinated but said each year, 80% to 90% of children who die from the flu were not vaccinated. Public Health estimates there are 70 to 500 flu-related deaths in King County each year. People who get the flu can be contagious a day before symptoms develop and up to a week after becoming sick, according to Public Health. Symptoms include fever, cough, weakness and body aches.

Output: King County child dies of flu.


Input: Consider Input: Novartis, with exclusive rights to the drug in Europe while cooperating with Amgen in the United States, said it was “disappointed” in the National Institute for Health and Care Excellence’s (NICE) conclusion. It marks the second time within months the UK agency has rejected reimbursement for a key medicine from the Swiss drugmaker. Novartis, whose U.K. price for Aimovig is about 5,000 pounds ($6,374) annually but which was offering discounts, is counting on the medicine to be a foundation of its neuroscience business and a key part of boosting revenue as older medicines lose patent protection. Some analysts see 2022 sales nearing $1 billion, according to Refinitiv. While NICE said the medicine demonstrated clinical effectiveness, the agency concluded there was not enough evidence to suggest it is more effective than botulinum toxin type A, which is marketed by Allergan as Botox. NICE also raised questions about long-term effectiveness. “We will work with the company to ensure that they are given every opportunity to address the issues highlighted in these provisional recommendations,” NICE said. Novartis, which pledged to work with NICE to address outstanding questions, said patients would lack new treatment options if the decision remains unchanged. “The UK already lags significantly behind other European countries in the ability for patients to access new medicines,” Novartis said. In September, NICE also issued draft guidance concluding Novartis’s cancer cell therapy Kymriah, offered with an undisclosed discount to its list price of 282,000 pounds, was too expensive to recommend to treat adults with lymphoma. Novartis is also seeking to reverse that decision.


Output: Novartis migraine drug not cost effective - UK price watchdog.